The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Dojcsák, D.,
Kardos, Z.,
Szabó, M.,
Oláh, C.,
Körömi, Z.,
Viskolcz, B.,
Váradi, C.:
The Alterations of Serum N-glycome in Response to SARS-CoV-2 Vaccination.
Int. J. Mol. Sci. 24 (7), 1-7, (article identifier: 6203), 2023.
Kardos, Z.,
Szabó, M.,
Baráth, Z.,
Miksi, Á.,
Oláh, C.,
Kozma, Á.,
Gergely, J. A.,
Csánky, E.,
Szekanecz, Z.:
Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: a Single-centre Retrospective Controlled Study.
Biomedicines. 11 (2), 1-15, (article identifier: 349), 2023.
Q1
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1
Medicine (miscellaneous)
2022
5.
Dézsi, L.,
Mészáros, T.,
Kozma, G.,
H-Velkei, M.,
Oláh, C.,
Szabó, M.,
Patkó, Z.,
Fülöp, T.,
Hennies, M.,
Szebeni, M.,
Barta, B. A.,
Merkely, B.,
Radovits, T.,
Szebeni, J.:
A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor.
GeroScience. 44 (2), 597-618, 2022.
Szabó, M.,
Sárközy, D.,
Szigeti, M.,
Farsang, R.,
Kardos, Z.,
Kozma, Á.,
Csánky, E.,
Chung, D. S.,
Szekanecz, Z.,
Guttman, A.:
Introduction of a Capillary Gel Electrophoresis-Based Workflow for Biotherapeutics Characterization: size, Charge, and N-Glycosylation Variant Analysis of Bamlanivimab, an Anti-SARS-CoV-2 Product.
Front. Bioeng. Biotechnol. 10, 1-9, (article identifier: 839374), 2022.
Szabó, M.,
Kardos, Z.,
Oláh, C.,
Tamáska, P.,
Hódosi, K.,
Csánky, E.,
Szekanecz, Z.:
Severity and prognostic factors of SARS-CoV-2-induced pneumonia: the value of clinical and laboratory biomarkers and the A-DROP score.
Front. Med. 9, 1-8, (article identifier: 920016), 2022.
Oláh, M.,
Kresznerits, S.,
Gonda, X.,
Perczel-Forintos, D.,
Szabó, M.,
Csánky, E.,
Meszáros, Á.:
Impact of education on dimensions of adherence in patients with chronic obstructive pulmonary disease.
Acta Poloniae Pharmaceutica - Drug Research. 77 (1), 195-204, 2020.
Szabó, M.,
Kun, R.,
Hajba, L.,
Koncz, R.,
Guttman, A.,
Csánky, E.:
Protein és glikán biomarkerek szerepe a krónikus obstruktív tüdőbetegség diagnosztikájában.
Orv. hetil. 161 (4), 123-128, 2020.
Szabó, M.,
Hajba, L.,
Kun, R.,
Guttman, A.,
Csánky, E.:
Proteomic and Glycomic Markers to Differentiate Lung Adenocarcinoma from COPD.
Curr. Med. Chem. 27 (20), 3302-3313, 2020.
Magorivska, I.,
Döncző, B.,
Dumych, T.,
Karmash, A.,
Boichuk, M.,
Hychka, K.,
Mihalj, M.,
Szabó, M.,
Csánky, E.,
Rech, J.,
Guttman, A.,
Vári, S. G.,
Bilyy, R.:
Glycosylation of random IgG distinguishes seropositive and seronegative rheumatoid arthritis.
Autoimmunity. 51 (3), 111-117, 2018.
Szabó, M.,
Jáger, M.,
Krizsó, E.,
Gilányi, I.,
Leny, A.,
Szűcs, G.,
Csánky, E.:
Chylothorax mint a coronaria-bypassműtét szövődménye = Chylothorax as a complication of coronary artery bypass grafting operation.
Orv. hetil. 153 (14), 553-558, 2012.
